Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

10.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.7K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scleroderma calcinosis cutis score (SC2S): an imaging metric to quantify SSc-calcinosis cutis.

Rheumatology (Oxford, England)·2026
Same author

Coronary microvascular dysfunction in systemic sclerosis: insights from PET-derived myocardial flow reserve.

Rheumatology (Oxford, England)·2026
Same author

Skin Transcriptomics Reveal Shared Molecular Mechanisms for Skin and Lung Involvement in Systemic Sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Insights Into Systemic Sclerosis from Gene Expression Profiling.

Current treatment options in rheumatology·2026
Same author

Insight from convergent validity of assessment of systemic sclerosis-associated Raynaud phenomenon with nailfold capillaroscopy.

Rheumatology advances in practice·2025
Same author

Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody.

Blood·2025

Related Experiment Video

Updated: Dec 1, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.6K

Molecular "omic" signatures in systemic sclerosis.

Bhaven K Mehta1, Monica E Espinoza1, Monique Hinchcliff2

  • 1Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

European Journal of Rheumatology
|November 9, 2020
PubMed
Summary

Systemic sclerosis (SSc) is a complex connective tissue disorder. Integrating diverse "omics" data, including genomic and epigenomic, is crucial for understanding SSc heterogeneity and advancing precision medicine.

More Related Videos

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.4K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.3K

Related Experiment Videos

Last Updated: Dec 1, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.6K
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.4K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.3K

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Systemic sclerosis (SSc) is a connective tissue disease with immunologic, vascular, and matrix abnormalities.
  • Clinical heterogeneity in SSc suggests variations in deregulated molecular pathway activation.
  • Recent advancements have yielded substantial
  • "omics" data in SSc research.

Purpose of the Study:

  • To review the existing
  • "omics" level research in Systemic sclerosis.
  • To highlight the insights gained from each
  • "omics" layer.
  • To emphasize the importance of integrating multi-omics data for SSc.

Main Methods:

  • Comprehensive literature review of
  • "omics" studies in Systemic sclerosis.
  • Analysis of genomic, transcriptomic, metagenomic, and epigenomic data.
  • Synthesis of findings to understand SSc pathogenesis and heterogeneity.

Main Results:

  • Each
  • "omics" layer provides distinct perspectives on SSc.
  • Genomic data reveals inherited predispositions.
  • Transcriptomic, epigenomic, and metagenomic data offer insights into dynamic molecular changes and environmental influences.

Conclusions:

  • Integrating diverse
  • "omics" data (genomic, transcriptomic, epigenomic, metagenomic) is essential for a holistic understanding of SSc.
  • Multi-omics integration is a critical step towards developing precision medicine approaches for SSc.
  • This integrated approach is vital for identifying targeted and effective therapies for SSc patients.